The company maintains a healthy financial position with minimal debt and a current ratio of 11.70, though this is offset by a $366.9M cumulative deficit in retained earnings.
| Total Current Assets | 241.66M | 167.32M | 88.96M | 63.86M | 98.84M | 94.79M |
| Cash & Short-Term Investments | 204.53M | 140.28M | 60.98M | 27.32M | 25.92M | 65.05M |
| Cash Only | 204.53M | 140.28M | 60.98M | 27.32M | 25.92M | 65.05M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 10.97M | 7.29M | 10.4M | 12.28M | 20.69M | 10.99M |
| Days Sales Outstanding | 36.85 | 36.67 | 49.91 | 68.36 | 82.97 | 78.73 |
| Inventory | 23.46M | 16.94M | 15.01M | 21.48M | 33.68M | 7.43M |
| Days Inventory Outstanding | 139.62 | 132.04 | 105.8 | 170.06 | 204.08 | 92.31 |
| Other Current Assets | 2.69M | 2.82M | 2.57M | 2.79M | 2.01M | 803K |
| Total Non-Current Assets | 17.86M | 17.36M | 15.32M | 8.57M | 6.29M | 4.9M |
| Property, Plant & Equipment | 6M | 4.78M | 3.54M | 2.97M | 5.49M | 3.2M |
| Fixed Asset Turnover | 15.82x | 15.19x | 21.46x | 22.04x | 16.57x | 15.94x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 11.46M | 11.59M | 11.73M | 5.56M | 700K | 1.62M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 391K | 993K | 49K | 40K | 96K | 81K |
| Total Assets | 259.52M | 184.68M | 104.28M | 72.43M | 105.13M | 99.68M |
| Asset Turnover | 0.45x | 0.39x | 0.73x | 0.90x | 0.87x | 0.51x |
| Asset Growth % | 238.47% | 77.1% | 43.97% | -31.1% | 5.46% | - |
| Total Current Liabilities | 20.65M | 19.18M | 11.77M | 12.92M | 14.8M | 6.08M |
| Accounts Payable | 8.29M | 8.58M | 2.93M | 2.41M | 11.04M | 2.81M |
| Days Payables Outstanding | 47.79 | 66.87 | 20.68 | 19.08 | 66.91 | 34.95 |
| Short-Term Debt | 982K | 400K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.38M | 7.4M | 1.7M | 1.55M | 34K | 15K |
| Current Ratio | 11.70x | 8.72x | 7.56x | 4.94x | 6.68x | 15.59x |
| Quick Ratio | 10.57x | 7.84x | 6.28x | 3.28x | 4.40x | 14.36x |
| Cash Conversion Cycle | 128.69 | 101.85 | 135.03 | 219.34 | 220.14 | 136.09 |
| Total Non-Current Liabilities | 3.71M | 3.04M | 6.76M | 382K | 1.32M | 1.3M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 2.28M | 278K | 333K | 219K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.55M | 2.76M | 6.43M | 163K | 1.32M | 1.3M |
| Total Liabilities | 24.36M | 22.22M | 18.53M | 13.3M | 16.12M | 7.38M |
| Total Debt | 2.14M | 678K | 966K | 1.02M | 0 | 0 |
| Net Debt | -202.39M | -139.6M | -60.02M | -26.3M | -25.92M | -65.05M |
| Debt / Equity | 0.01x | 0.00x | 0.01x | 0.02x | - | - |
| Debt / EBITDA | -0.06x | - | - | - | - | - |
| Net Debt / EBITDA | 5.71x | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -4.42x |
| Total Equity | 235.16M | 162.46M | 85.75M | 59.13M | 89.01M | 92.3M |
| Equity Growth % | 289.28% | 89.46% | 45.01% | -33.56% | -3.57% | - |
| Book Value per Share | 11.53 | 20.37 | 6.30 | 5.66 | 0.36 | 6.78 |
| Total Shareholders' Equity | 235.16M | 162.46M | 85.75M | 59.13M | 89.01M | 92.3M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -366.88M | -356.71M | -320.25M | -277.87M | -158.1M | -132.75M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -375K | -440K | -520K | -839K | 200K | 24K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Persistent Operating Cash Burn
According to recent balance sheet data, Ambiq's total assets expanded from $89.2M in 2025Q2 to $259.5M by 2026Q1, reflecting a significant strengthening of the company's financial base that appears to be driven by external capital injections rather than organic earnings accumulation.
The rapid expansion of the asset base suggests that the company has successfully secured funding to support its R&D-heavy business model. Investors should monitor whether this capital influx is sufficient to bridge the gap to profitability, as the persistent negative retained earnings of -$366.9M indicate that the firm remains in a deep investment phase.
As reported in financial statements, Ambiq maintains a current ratio of 11.70 as of 2026Q1, providing a substantial liquidity buffer that appears to mitigate immediate solvency concerns despite the company's ongoing operational cash burn and high R&D requirements.
The high current ratio is largely supported by a cash position of $204.5M, which provides management with significant flexibility to navigate cyclical downturns in the wearable semiconductor market. This liquidity profile appears adequate to fund operations in the near term, though it warrants further investigation into the burn rate relative to future product development milestones.
Based on reported figures, Ambiq's equity base has grown to $235.2M in 2026Q1, yet this figure is heavily offset by a cumulative deficit in retained earnings of $366.9M, suggesting that historical value creation has been consistently eroded by operating losses.
The reliance on external equity to maintain a positive book value indicates that the company's business model has yet to achieve the scale necessary for self-sustaining growth. Analysts should consider the potential for future dilution if the current trajectory of negative earnings persists, as the equity base is currently dependent on capital raises rather than operational success.
While the balance sheet appears healthy with minimal debt, the presence of $11.5M in goodwill and a heavy reliance on cash reserves suggests that the company's underlying asset quality is sensitive to potential impairment risks and the high cost of maintaining its proprietary technology.
The lack of significant tangible assets relative to the company's R&D spend implies that the firm's value is almost entirely tied to intangible intellectual property. Investors should monitor whether the carrying value of these intangibles remains justified, as any failure to commercialize the Atomiq platform could lead to significant write-downs that would impair the current equity position.
Quick answers to the most common questions about buying AMBQ stock.
As of 2025, Ambiq Micro, Inc. (AMBQ) had total assets of $184.7M including $167.3M in current assets.
Ambiq Micro, Inc. (AMBQ) carries total debt of $0.7M, offset by $140.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Ambiq Micro, Inc. (AMBQ) has total shareholders' equity (book value) of $162.5M ($20.37 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Ambiq Micro, Inc. (AMBQ) reported a current ratio of 8.72x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.